Quest Diagnostics DGX reported its Q3 earnings results on Thursday, October 20, 2022 at 06:45 AM.
Here's what investors need to know about the announcement.
Earnings
Quest Diagnostics beat estimated earnings by 8.76%, reporting an EPS of $2.36 versus an estimate of $2.17.
Revenue was down $288.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.16 which was followed by a 2.67% drop in the share price the next day.
Here's a look at Quest Diagnostics's past performance:
Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
---|---|---|---|---|
EPS Estimate | 2.20 | 2.97 | 3.17 | 2.87 |
EPS Actual | 2.36 | 3.22 | 3.33 | 3.96 |
Revenue Estimate | 2.34B | 2.63B | 2.66B | 2.45B |
Revenue Actual | 2.45B | 2.61B | 2.74B | 2.77B |
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Guidance
Quest Diagnostics management provided guidance for FY 2022, expecting earnings between $9.75 and $9.95 per share.
To track all earnings releases for Quest Diagnostics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.